Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Filings indexed 1,765 across all filing types
Latest filing 2022-05-21 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Board Meeting — Bonus
Regulatory Filings
2022-05-21 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve In furtherance to ....
Capital/Financing Update Classification · 95% confidence The document is a short letter addressed to stock exchanges informing about a scheduled Board meeting where a proposal for issuance of Bonus shares will be considered. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in share capital or corporate actions. The document is brief (1277 characters) and serves as an intimation or announcement rather than a detailed report or financial statement. It does not contain financial data or detailed analysis but is an update on a capital-related corporate action. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-05-21 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th May, 2022 at 07:00 P.M. to discuss the financial performance of the Company for the quarter ....
Call Transcript Classification · 70% confidence The document is a short notice informing about a scheduled teleconference (conference call) with investors and analysts to discuss the financial performance for the quarter and year ended 31st March 2022. It provides dial-in details for the call but does not contain any financial data, analysis, or the actual transcript of the call. The document length is only 2286 characters, which is quite short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or notice, but since it is only announcing the call and not providing the transcript, it fits the category of Call Transcript (CT) as it relates to the conference call event. Given the content and context, the best fit is Call Transcript (CT) with moderate confidence due to the announcement nature of the document.
2022-05-20 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about a scheduled teleconference (conference call) with investors and analysts to discuss the financial performance for the quarter and year ended 31st March 2022. It provides dial-in details for the call but does not contain any financial data or results itself. The document is short (2390 characters) and serves as an announcement of a conference call rather than the transcript or financial report. Therefore, it fits the category of a Call Transcript announcement or notification. Since it is not the transcript itself but a notice of the call, the best fitting category is Call Transcript (CT).
2022-05-20 English
Loss of share certificate
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges of the issuance of duplicate share certificates to shareholders, including details such as folio numbers, shareholder names, number of shares, and certificate numbers. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an announcement related to share certificates, which falls under the category of share capital changes or share-related corporate actions. According to the filing definitions, announcements regarding share certificates and capital changes are best classified under Share Issue/Capital Change (SHA). The document length is short (1885 characters), and it is not a report publication or certification. Therefore, the appropriate classification is SHA with high confidence.
2022-05-16 English
Intimation of Issue of Duplicate Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges of a corporate action related to share certificates, not about financial results, management changes, or other report types. The document length is short (1897 characters) and it is an announcement of a corporate action related to shares. This fits best under the category of Share Issue/Capital Change (SHA), as it involves issuance of duplicate share certificates, which is a capital-related event but not a new share issue or buyback. However, since the issuance of duplicate share certificates is a capital-related notification, SHA is the most appropriate classification.
2022-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.